During the past decade, Smilow Cancer Hospital Care Center at Glastonbury conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Smilow Cancer Hospital Care Center at Glastonbury" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Smilow Cancer Hospital Care Center at Glastonbury" are "Breast Carcinoma" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "HER2/Neu Negative" (2 trials), "Invasive Breast Carcinoma" (2 trials) and "Pancreatic Carcinoma" (2 trials). Many other conditions were trialed in "Smilow Cancer Hospital Care Center at Glastonbury" in a lesser frequency.

Most popular intervention types in "Smilow Cancer Hospital Care Center at Glastonbury" are "Other" (12 trials), "Drug" (10 trials), "Biological" (9 trials), "Procedure" (5 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Computed Tomography" (4 trials), "Questionnaire Administration" (4 trials), "Magnetic Resonance Imaging" (3 trials) and "Pertuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Smilow Cancer Hospital Care Center at Glastonbury" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Smilow Cancer Hospital Care Center at Glastonbury". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Smilow Cancer Hospital Care Center at Glastonbury, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Smilow Cancer Hospital Care Center at Glastonbury, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".